A detailed history of Hsbc Holdings PLC transactions in Haleon PLC stock. As of the latest transaction made, Hsbc Holdings PLC holds 35,876 shares of HLN stock, worth $379,209. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,876
Previous 15,427 132.55%
Holding current value
$379,209
Previous $130,000 127.69%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$8.01 - $8.64 $163,796 - $176,679
20,449 Added 132.55%
35,876 $296,000
Q1 2024

May 15, 2024

SELL
$8.02 - $8.67 $22,680 - $24,518
-2,828 Reduced 15.49%
15,427 $130,000
Q4 2023

Feb 12, 2024

BUY
$7.78 - $8.62 $28,529 - $31,609
3,667 Added 25.14%
18,255 $150,000
Q3 2023

Nov 13, 2023

BUY
$7.85 - $8.94 $114,515 - $130,416
14,588 New
14,588 $121,000
Q1 2023

May 15, 2023

BUY
$7.57 - $8.37 $100,082 - $110,659
13,221 New
13,221 $107,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $48.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.